STING1 and neoplasm: Overall, DDR inhibition functions as a two-pronged immunogenic strategy—directly inducing tumor cell death while simultaneously converting genomic instability into a proinflammatory, interferon-rich state that can be harnessed by checkpoint blockade or STING agonism.